Chunze Li

2.5k total citations
93 papers, 1.6k citations indexed

About

Chunze Li is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Chunze Li has authored 93 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 33 papers in Radiology, Nuclear Medicine and Imaging and 19 papers in Molecular Biology. Recurrent topics in Chunze Li's work include HER2/EGFR in Cancer Research (34 papers), Monoclonal and Polyclonal Antibodies Research (30 papers) and Lymphoma Diagnosis and Treatment (13 papers). Chunze Li is often cited by papers focused on HER2/EGFR in Cancer Research (34 papers), Monoclonal and Polyclonal Antibodies Research (30 papers) and Lymphoma Diagnosis and Treatment (13 papers). Chunze Li collaborates with scholars based in United States, France and Switzerland. Chunze Li's co-authors include Mark P. Grillo, Leslie Z. Benet, Sandhya Girish, Jin Y. Jin, Divya Samineni, Dan Lu, Dale Miles, Thomayant Prueksaritanont, Matts Kågedal and Priya Agarwal and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Chunze Li

90 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chunze Li United States	24	649	425	404	259	147	93	1.6k
Jin Y. Jin United States	24	732 1.1×	538 1.3×	384 1.0×	197 0.8×	204 1.4×	95	1.9k
Wenqi Jiang China	19	759 1.2×	403 0.9×	83 0.2×	223 0.9×	148 1.0×	43	1.6k
Ivan Nestorov United States	30	409 0.6×	463 1.1×	423 1.0×	335 1.3×	623 4.2×	88	2.5k
Nehmé El-Hachem Canada	19	297 0.5×	892 2.1×	351 0.9×	69 0.3×	121 0.8×	50	1.9k
Jürgen Geisler Norway	36	2.5k 3.8×	1.3k 3.2×	297 0.7×	133 0.5×	261 1.8×	146	5.1k
Lei Yan China	17	639 1.0×	1.0k 2.4×	92 0.2×	46 0.2×	121 0.8×	62	2.1k
Yongyu Wang China	22	476 0.7×	1.4k 3.2×	117 0.3×	94 0.4×	146 1.0×	79	2.9k
Balaji Agoram United States	18	306 0.5×	331 0.8×	154 0.4×	192 0.7×	344 2.3×	46	1.3k
Shinji Yamazaki United States	25	1.2k 1.8×	1.4k 3.3×	78 0.2×	266 1.0×	117 0.8×	76	3.0k
Tong Zhang China	29	1.8k 2.8×	1.5k 3.6×	510 1.3×	48 0.2×	205 1.4×	162	4.5k

Countries citing papers authored by Chunze Li

Since Specialization

Citations

This map shows the geographic impact of Chunze Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunze Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunze Li more than expected).

Fields of papers citing papers by Chunze Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunze Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunze Li. The network helps show where Chunze Li may publish in the future.

Co-authorship network of co-authors of Chunze Li

This figure shows the co-authorship network connecting the top 25 collaborators of Chunze Li. A scholar is included among the top collaborators of Chunze Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunze Li. Chunze Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Junying, et al.. (2025). Evaluations of Backfill Strategies in Dose Optimization through Simulation Studies for Phase I Trials in Oncology. Statistics in Biopharmaceutical Research. 1–11.

Yip, Victor, et al.. (2024). Monomethyl auristatin E (MMAE), a payload for multiple antibody drug conjugates (ADCs), demonstrates differential red blood cell partitioning across human and animal species. Xenobiotica. 54(8). 511–520. 4 indexed citations

Hamed, Salaheldin S., et al.. (2024). Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization. Clinical and Translational Science. 17(3). e13759–e13759. 3 indexed citations

Turner, David C., et al.. (2023). Pharmacokinetics of biologics in gastric cancer. Clinical and Translational Science. 16(4). 564–574. 4 indexed citations

Bruno, René, Pascal Chanu, Matts Kågedal, et al.. (2023). Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models. British Journal of Cancer. 129(9). 1383–1388. 13 indexed citations

Shemesh, Colby S., Phyllis Chan, Mathilde Marchand, et al.. (2023). Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition‐Survival Modeling Framework. Clinical Pharmacology & Therapeutics. 114(3). 644–651. 4 indexed citations

Bruno, René, Mathilde Marchand, Kenta Yoshida, et al.. (2023). Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150. Clinical Cancer Research. 29(6). 1047–1055. 13 indexed citations

Yoshida, Kenta, Vikram Malhi, Chunze Li, et al.. (2023). Concentration QTc analysis of giredestrant: Overcoming QT/heart rate confounding in the presence of drug‐induced heart rate changes. Clinical and Translational Science. 16(5). 823–834. 2 indexed citations

Liao, Michael Z., Rong Deng, Leonid Gibiansky, et al.. (2023). Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX. Clinical and Translational Science. 16(12). 2744–2755. 3 indexed citations

10.

Herrera, Alex F., Manish R. Patel, John M. Burke, et al.. (2022). Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study. Clinical Cancer Research. 28(7). 1294–1301. 21 indexed citations

11.

Prébet, Thomas, Aaron D. Goldberg, Joseph G. Jurcic, et al.. (2022). A phase 1b study of atezolizumab in combination with guadecitabine for the treatment of acute myeloid leukemia. Leukemia & lymphoma. 63(9). 2180–2188. 6 indexed citations

12.

Samineni, Divya, Leonid Gibiansky, Bei Wang, et al.. (2022). Pharmacokinetics and Exposure-Response Analysis of Venetoclax + Obinutuzumab in Chronic Lymphocytic Leukemia: Phase 1b Study and Phase 3 CLL14 Trial. Advances in Therapy. 39(8). 3635–3653. 7 indexed citations

13.

Wang, Bei, Rong Deng, Stefanie Hennig, et al.. (2021). Population pharmacokinetic and exploratory exposure–response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study. Cancer Chemotherapy and Pharmacology. 88(3). 499–512. 11 indexed citations

14.

Ning, Jun, et al.. (2020). COLREGs-Compliant Unmanned Surface Vehicles Collision Avoidance Based on Multi-Objective Genetic Algorithm. IEEE Access. 8. 190367–190377. 42 indexed citations

15.

Shemesh, Colby S., Priya Agarwal, Tong Lu, et al.. (2020). Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma. Cancer Chemotherapy and Pharmacology. 85(5). 831–842. 11 indexed citations

16.

Lü, Dan, Tong Lu, Leonid Gibiansky, et al.. (2020). Application of a Two-Analyte Integrated Population Pharmacokinetic Model to Evaluate the Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Polatuzumab Vedotin in Patients with Non-Hodgkin Lymphoma. Pharmaceutical Research. 37(12). 252–252. 13 indexed citations

17.

Quartino, Angelica, Matthew Riggs, Jonathan French, et al.. (2017). Population pharmacokinetics and exposure–response of trastuzumab emtansine in advanced breast cancer previously treated with ≥2 HER2‐targeted regimens. British Journal of Clinical Pharmacology. 83(12). 2767–2777. 17 indexed citations

18.

Chen, Yuan, Divya Samineni, Sophie Mukadam, et al.. (2014). Physiologically Based Pharmacokinetic Modeling as a Tool to Predict Drug Interactions for Antibody-Drug Conjugates. Clinical Pharmacokinetics. 54(1). 81–93. 32 indexed citations

19.

Wynne, Chris, R. B. Ellis‐Pegler, Christian Schwabe, et al.. (2013). Comparative pharmacokinetics of subcutaneous trastuzumab administered via handheld syringe or proprietary single-use injection device in healthy males. Cancer Chemotherapy and Pharmacology. 72(5). 1079–1087. 19 indexed citations

20.

Li, Chunze, et al.. (1998). A Robust Method for Determining DNA Binding Constants Using Capillary Zone Electrophoresis. Analytical Biochemistry. 263(1). 72–78. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact